[go: up one dir, main page]

PT98725A - Metodo para a producao de virus de arn a partir de adn complementar - Google Patents

Metodo para a producao de virus de arn a partir de adn complementar

Info

Publication number
PT98725A
PT98725A PT98725A PT9872591A PT98725A PT 98725 A PT98725 A PT 98725A PT 98725 A PT98725 A PT 98725A PT 9872591 A PT9872591 A PT 9872591A PT 98725 A PT98725 A PT 98725A
Authority
PT
Portugal
Prior art keywords
rna virus
methods
cdna
production
complementary dna
Prior art date
Application number
PT98725A
Other languages
English (en)
Other versions
PT98725B (pt
Inventor
Vincent Racaniello
Joanne Marie Tatem
Carolyn L Weeks-Levy
Original Assignee
Univ Columbia
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Columbia filed Critical Univ Columbia
Publication of PT98725A publication Critical patent/PT98725A/pt
Publication of PT98725B publication Critical patent/PT98725B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K40/00—Cellular immunotherapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2770/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses positive-sense
    • C12N2770/00011—Details
    • C12N2770/32011—Picornaviridae
    • C12N2770/32611—Poliovirus
    • C12N2770/32622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Immunology (AREA)
  • Veterinary Medicine (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
PT98725A 1990-08-20 1991-08-20 Metodo para a producao de virus de arn a partir de adn complementar PT98725B (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US57000090A 1990-08-20 1990-08-20
US56991690A 1990-08-20 1990-08-20

Publications (2)

Publication Number Publication Date
PT98725A true PT98725A (pt) 1992-07-31
PT98725B PT98725B (pt) 1999-01-29

Family

ID=27075179

Family Applications (1)

Application Number Title Priority Date Filing Date
PT98725A PT98725B (pt) 1990-08-20 1991-08-20 Metodo para a producao de virus de arn a partir de adn complementar

Country Status (12)

Country Link
US (5) US5525715A (pt)
EP (1) EP0496875B1 (pt)
JP (1) JPH05503634A (pt)
KR (1) KR100230195B1 (pt)
AT (1) ATE212056T1 (pt)
AU (1) AU656328B2 (pt)
CA (1) CA2067337A1 (pt)
DE (1) DE69132900D1 (pt)
IL (1) IL99232A0 (pt)
NO (1) NO303943B1 (pt)
PT (1) PT98725B (pt)
WO (1) WO1992003538A1 (pt)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0563487A1 (en) 1992-03-31 1993-10-06 Laboratoire Europeen De Biotechnologie S.A. Monoclonal antibodies against the interferon receptor, with neutralizing activity against type I interferon
EP0660258B1 (en) * 1993-12-20 2000-03-08 Seiko Epson Corporation Electronic pointing device
US6071745A (en) * 1997-06-27 2000-06-06 Bio-Rad Laboratories Method and formulation for lyophilizing cultured human cells to preserve RNA and DNA contained in cells for use in molecular biology experiments
US6846655B1 (en) * 1998-06-29 2005-01-25 Phylos, Inc. Methods for generating highly diverse libraries
WO2001078789A2 (en) 2000-04-14 2001-10-25 The Uab Research Foundation Poliovirus replicons encoding therapeutic agents and uses thereof
US20030092035A1 (en) * 2000-05-04 2003-05-15 Anderson David J. Pain signaling molecules
AU2002306709A1 (en) * 2001-03-14 2002-09-24 Replicon Technologies, Inc. Oncolytic rna replicons
WO2016201224A1 (en) 2015-06-10 2016-12-15 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Processes for production and purification of nucleic acid-containing compositions
EP3569618A1 (en) 2018-05-19 2019-11-20 Boehringer Ingelheim International GmbH Antagonizing cd73 antibody

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor

Also Published As

Publication number Publication date
PT98725B (pt) 1999-01-29
EP0496875B1 (en) 2002-01-16
EP0496875A4 (en) 1993-12-29
NO303943B1 (no) 1998-09-28
EP0496875A1 (en) 1992-08-05
AU8533391A (en) 1992-03-17
ATE212056T1 (de) 2002-02-15
NO921472D0 (no) 1992-04-13
AU656328B2 (en) 1995-02-02
IL99232A0 (en) 1992-07-15
KR920702411A (ko) 1992-09-04
NO921472L (no) 1992-04-13
DE69132900D1 (de) 2002-02-21
CA2067337A1 (en) 1992-02-21
US5683901A (en) 1997-11-04
JPH05503634A (ja) 1993-06-17
US5834302A (en) 1998-11-10
KR100230195B1 (ko) 1999-11-15
US6136570A (en) 2000-10-24
US5525715A (en) 1996-06-11
US5580719A (en) 1996-12-03
WO1992003538A1 (en) 1992-03-05

Similar Documents

Publication Publication Date Title
ATE64152T1 (de) Herstellung von staerken des bacillus thuringiensis mit aktivitaet gegen bestimmte lepidoptaere schaedlinge und dadurch erhaltener stamm.
DK0443449T3 (da) Fremgangsmåde til fremstilling af oxetanoner
DK368588D0 (da) Bindingsmolekyler med en enkelt plypeptidkaede
FI954360A0 (fi) Kasvaimen hyljintäantigeenin esiastetta koodittava nukseiinihappo
ATE553125T1 (de) Herstellung eines multimeren proteins durch zellfusionsverfahren
SE8601325L (sv) Sett att producera ett immunglobulinbindande protein samt medel for detta
DK0763128T3 (da) Fremgangsmåde til fremstilling af heterologe bispecifikke antistoffer
PT98725A (pt) Metodo para a producao de virus de arn a partir de adn complementar
DK0515511T3 (da) Fremgangsmåde til sted-specifik ændring af RNA og fremstilling af kodende polypeptider
EA200200565A1 (ru) Применение клеток, трансфицированных днк, кодирующей лиганд мнс класса ii, и способ получения таких клеток
DK0787124T3 (da) Fremgangsmåde til fremstilling af substituerede 3-aminobenzonitriler
FI924575A (fi) Nya t-cellymfom-cdna-kloner
DE69810959D1 (de) Verfahren zur herstellung von pyrrolamiden
DK0758336T3 (da) Fremgangsmåde til fremstilling af 1-(3-trialkylsilylphenyl)-2,2,2-trifluorethanonderivater
SE8403929L (sv) Rekombinant-dna-molekyl, transformerade mikroorganismer och forfarande for framstellning av penicillin v-amidas
MX9700941A (es) Materiales y metodos para la produccion de icam-4.
ATE244709T1 (de) Verfahren zur herstellung von benzofuranonoximen
SU673632A1 (ru) Способ термообработки сырцовых керамзитовых гранул
SU810177A1 (ru) Способ выкормки тутового шелкопр да
ATE108832T1 (de) Verwendung von monoklonalen antikörpern gegen b2- mikroglobulin.
DE59302025D1 (de) Verfahren zum Umbau von Spaltöfen
EA200000788A1 (ru) Способ получения производных цианофенола

Legal Events

Date Code Title Description
BB1A Laying open of patent application

Effective date: 19920318

FG3A Patent granted, date of granting

Effective date: 19981026